Francesco Passamonti

No ORCID on file · 3 papers in corpus · active 2023-2025

Study types

  • article 3
article 2025
Danazol treatment for poor graft function after hematopoietic stem cell transplantation: a single centre experience
·doi:10.1038/s41409-025-02790-0
article 2023
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
·doi:10.1016/s0140-6736(22)02036-0
article 2023
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis previously treated with a JAK inhibitor (MOMENTUM): an updated analysis of an international, double-blind, randomised phase 3 study
·doi:10.1016/s2352-3026(23)00174-6